Securities regulators say the role of Ipsen employee Dishant Gupta made him privy to details of the Epizyme acquisition. Gupta allegedly accumulated Epizyme shares while the deal was negotiated, then sold all of them hours after the transaction was announced.
Ipsen is paying $247 million to acquire Epizyme, a cancer drug developer with one FDA-approved product: follicular lymphoma therapy Tazverik. The drug is a modest seller now, but more cash could be paid out if the small molecule hits sales targets in coming years.
The layout of your phlebotomy station can significantly impact efficiency. A well-thought-out setup ensures that every tool is within reach, minimizing unnecessary movement and reducing patient wait times.
The company said the FDA had accepted its application for accelerated approval of Tazverik in relapsed/refractory follicular lymphoma. The drug won accelerated approval last month for epithelioid sarcoma.
The agency gave accelerated approval to Tazverik in epithelioid sarcoma, a rare but serious connective tissue cancer. The company is also seeking approval for the drug, an EZH2 inhibitor, for the blood cancer follicular lymphoma.
The agency's Oncologic Drugs Advisory Committee voted unanimously to recommend approval of tazemetostat for epithelioid sarcoma. The company has said it would likely use drugs like Bristol-Myers Squibb's Revlimid as a benchmark for pricing.
The company said Thursday the agency had accepted its accelerated approval application for tazemetostat in epithelioid sarcoma. An analyst wrote that an FDA advisory committee meeting is likely to happen in the fourth quarter.
Discover what tools are essential for efficient, safe surgical extractions in today’s health care landscape, from elevators to forceps and beyond.
The company plans to bring NGS to health systems lacking the ability to perform it internally.
Company will pursue RNA-modifying protein targets to discover and develop new treatments in oncology.
There’s an evolutionary benefit to being a risk-taker: Our loincloth-adorned forebears needed, after all, a fearless leader to explore uncharted, food-filled territory. In today’s society, who possesses these genes? Biotech leaders simply must be among the carriers, argues Louis Garguilo of Outsourced Pharma. He writes: Who might express this risk-taking gene in our industry if not the […]
Taking a fresh approach with a metabolic pathway that spurs cancer growth, spanking-new Cambridge cancer drug startup Raze Therapeutics has just raised a $24 million Series A. The company’s already got strong venture and big pharma backing – this early round includes Atlas Ventures, MPM Capital Management, MS Ventures, Partners Innovation Fund, Astellas Venture Management and […]
Finding the best analytics tools for health care revenue management can revolutionize operational processes. Compare the leading software options to discover helpful team resources.